Identifying Expression Markers of Cumulus Cells to Identify Oocyte Developmental Potential Through a Maturation Analysis

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Total Enrollment

200 participants

Study Classification

OBSERVATIONAL

Study Start Date

2014-08-31

Study Completion Date

2016-09-30

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The aim of the study is to analyze the expression of genes and microRNAs potentially involved in oocyte competence in follicles of different sizes (\<17mm and ≥17mm) at the time of oocyte pick-up.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Effect of Duration and Follicle Diameter During Oocyte Pick up on Embryological Parameters

NCT05666401

Follicle Size Embryologic Parameters Duration

COMPLETED

Comparison of Follicle Diameter on hCG Day and Follicle Diameters on OPU (Oocyte Pick up) Day and the Effect of Follicle Diameters on Embryo Development and Pregnancy Outcomes

NCT04679688

HCG Day Follicle Diameter, Reproduction Results

UNKNOWN NA

The Effect of Follicular Flushing on Oocyte Retrieval Rate and Embryo Quality

NCT05584436

Infertility

ACTIVE_NOT_RECRUITING

Outcomes of the Embryos of Different Ovarian Follicle Sizes, and the miRNA Detection in Their Blastocyst Culture

NCT05947526

Embryo Quality

UNKNOWN

The Role of DNA Damage of Granulosa Cell on Oocyte Quality and in Vitro Fertilization Outcome

NCT03345030

in Vitro Fertilization

UNKNOWN

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

In ART, one of the major obstacles encountered in some patients is the wide variation in the follicular size at the oocyte pick-up day and consequently, the number of available mature oocytes and the number of competent embryos for implantation. The follicular size at the day of oocyte pick-up reflects the synchronicity of the individual follicular responsiveness to FSH.

For successful preimplantation development of an embryo, the oocyte must contain all necessary maternal factors. Two of these factors are specific mRNA transcripts (GDF9, PTX3, HAS2, PTGS2, TNFAIP6) and microRNA (miR-224).

For each Cumulus Oocyte Complex, the evaluation of embryo development and morphokinetics will be correlated with the expression and implantation data to identify a quantitative biomarker to predict the embryo with the highest chance of implantation in patients.

Experimental Design:

1. \- Collection of Cumulus Oocyte Complex (COC) from patients
2. \- Separation of oocytes according to the size of the follicule they have been retrieved from (\<17mm; ≥17mm)
3. \- Isolation of mRNA from both groups of cumulus cells
4. \- Expression studies, qRT-PCR (GDF9, PTX3, HAS2, PTGS2, TNFAIP6)
5. \- Analysis of miR-224, a negative regulator of cumulus expansion via PTX3
6. \- Time-lapse culture \& evaluation of morphokinetics

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Infertility

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

COHORT

Study Time Perspective

PROSPECTIVE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* No more than 2 previous treatment cycles
* No history of recurrent spontaneous abortions
* Age ≤ 39 years
* BMI \< 30 kg / m2
* ≥ 8 cumulus-oocyte-complexes (COC) retrieved
* human Chorionic Gonadotrophin (hCG) triggering

Exclusion Criteria

* Preimplantaion Genetic Diagnosis (PGD) or Preimplantation Genetics Screening (PGS) indication
* Maximum number of 24 COC during pickup
* Failure to culture until Day 5
* Polycystic ovary syndrome
* Severe endometrial factor that can influence implantation
* Uterine malformation or congenital anomaly
* Severe male factor (Azoospermia)

Minimum Eligible Age

18 Years

Maximum Eligible Age

39 Years

Eligible Sex

FEMALE

Accepts Healthy Volunteers

No